Piper Sandler Lowers Vicarious Surgical (NYSE:RBOT) Price Target to $8.50

Vicarious Surgical (NYSE:RBOT) had its target price cut by equities researchers at Piper Sandler from $10.50 to $8.50 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Piper Sandler’s price target points to a potential upside of 5.52% from the stock’s previous close.

Vicarious Surgical Stock Down 1.8 %

Shares of RBOT opened at $8.06 on Tuesday. Vicarious Surgical has a 52 week low of $4.27 and a 52 week high of $19.00. The company has a market capitalization of $47.59 million, a price-to-earnings ratio of -0.78 and a beta of 1.35. The stock’s 50-day moving average price is $12.43 and its 200-day moving average price is $10.58.

Vicarious Surgical (NYSE:RBOT) last issued its earnings results on Monday, March 17th. The company reported ($2.43) EPS for the quarter, topping analysts’ consensus estimates of ($2.69) by $0.26. The company had revenue of $2.09 million during the quarter. During the same quarter last year, the firm earned ($2.25) EPS. As a group, equities analysts anticipate that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Trading of Vicarious Surgical

A number of hedge funds have recently modified their holdings of RBOT. DnB Asset Management AS boosted its position in Vicarious Surgical by 21.1% during the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after purchasing an additional 3,692 shares in the last quarter. Geode Capital Management LLC boosted its position in Vicarious Surgical by 8.2% during the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after purchasing an additional 2,336 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its position in Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock worth $152,000 after purchasing an additional 1,200 shares in the last quarter. Hedge funds and other institutional investors own 47.27% of the company’s stock.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.